Zobrazeno 1 - 10
of 601
pro vyhledávání: '"Huanhuan L"'
Autor:
Kiavash Mirzadeh, Patrick J. Shilling, Rageia Elfageih, Alister J. Cumming, Huanhuan L. Cui, Maja Rennig, Morten H. H. Nørholm, Daniel O. Daley
Publikováno v:
Microbial Cell Factories, Vol 19, Iss 1, Pp 1-12 (2020)
Abstract Background Recombinant proteins are often engineered with an N-terminal signal peptide, which facilitates their secretion to the oxidising environment of the periplasm (gram-negative bacteria) or the culture supernatant (gram-positive bacter
Externí odkaz:
https://doaj.org/article/3d4522af475f4477a00ac0d684dd7b7e
Autor:
Angelique Flöter Rådestad, Atosa Estekizadeh, Huanhuan L Cui, Ourania N. Kostopoulou, Belghis Davoudi, Angelica Lindén Hirschberg, Joseph Carlson, Afsar Rahbar, Cecilia Söderberg-Naucler
Publikováno v:
Translational Oncology, Vol 11, Iss 6, Pp 1292-1300 (2018)
Human cytomegalovirus (HCMV) has been detected in various types of tumors. We studied the prevalence of HCMV in ovarian cancer and its relation to clinical outcome. Paraffin-embedded tissues obtained prospectively from 45 patients with ovarian cancer
Externí odkaz:
https://doaj.org/article/3cf15a01da464fac9a153d7dda5f954e
Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
Autor:
Suhas Vasaikar, Giorgos Tsipras, Natalia Landázuri, Helena Costa, Vanessa Wilhelmi, Patrick Scicluna, Huanhuan L. Cui, Abdul-Aleem Mohammad, Belghis Davoudi, Mingmei Shang, Sharan Ananthaseshan, Klas Strååt, Giuseppe Stragliotto, Afsar Rahbar, Kum Thong Wong, Jesper Tegner, Koon-Chu Yaiw, Cecilia Söderberg-Naucler
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Glioblastoma (GBM) is the most common malignant brain tumor with median survival of 12-15 months. Owing to uncertainty in clinical outcome, additional prognostic marker(s) apart from existing markers are needed. Since overexpressi
Externí odkaz:
https://doaj.org/article/eb7a314e54f24c7e91cc8421104d2f9d
Autor:
Hann Low, Nigora Mukhamedova, Huanhuan L. Cui, Brian P. McSharry, Selmir Avdic, Anh Hoang, Michael Ditiatkovski, Yingying Liu, Ying Fu, Peter J. Meikle, Martin Blomberg, Konstantinos A. Polyzos, William E. Miller, Piotr Religa, Michael Bukrinsky, Cecilia Soderberg-Naucler, Barry Slobedman, Dmitri Sviridov
Publikováno v:
Cell Reports, Vol 16, Iss 1, Pp 186-200 (2016)
Cytomegalovirus (HCMV) contains cholesterol, but how HCMV interacts with host cholesterol metabolism is unknown. We found that, in human fibroblasts, HCMV infection increased the efflux of cellular cholesterol, despite reducing the abundance of ABCA1
Externí odkaz:
https://doaj.org/article/3e8942e781bd49fe8b389bb8108a2d62
Autor:
Wen-Kuan Huang, Jiwei Gao, Ziqing Chen, Hao Shi, Juan Yuan, Huanhuan L. Cui, Chun-Nan Yeh, Robert Bränström, Catharina Larsson, Shuijie Li, Weng-Onn Lui
Publikováno v:
Cells, Vol 9, Iss 6, p 1333 (2020)
Metabolic reprogramming is a hallmark of cancer cells in response to targeted therapy. Decreased glycolytic activity with enhanced mitochondrial respiration secondary to imatinib has been shown in imatinib-sensitive gastrointestional stromal tumors (
Externí odkaz:
https://doaj.org/article/489f29abb25a481ca1e9a184e147d483
Autor:
Afsar Rahbar, Amira AlKharusi, Helena Costa, Mattia Russel Pantalone, Ourania N. Kostopoulou, Huanhuan L. Cui, Joseph Carlsson, Angelique Flöter Rådestad, Cecilia Söderberg-Naucler, Gunnar Norstedt
Publikováno v:
Biology, Vol 9, Iss 3, p 44 (2020)
One of the potential biomarkers for ovarian cancer patients is high serum level of prolactin (PRL), which is a growth factor that may promote tumor cell growth. The prolactin receptor (PRLR) and human cytomegalovirus (HCMV) proteins are frequently de
Externí odkaz:
https://doaj.org/article/10065153a7274f8f9ee5daa8cb8f1330
Autor:
Huanhuan L. Cui, Angela Grant, Nigora Mukhamedova, Tatiana Pushkarsky, Lucas Jennelle, Larisa Dubrovsky, Katharina Gaus, Michael L. Fitzgerald, Dmitri Sviridov, Michael Bukrinsky
Publikováno v:
Journal of Lipid Research, Vol 53, Iss 4, Pp 696-708 (2012)
HIV infection, through the actions of viral accessory protein Nef, impairs activity of cholesterol transporter ABCA1, inhibiting cholesterol efflux from macrophages and elevating the risk of atherosclerosis. Nef also induces lipid raft formation. In
Externí odkaz:
https://doaj.org/article/e59aa69992e94a1c893ec568bab6cedd
Autor:
Rådestad, Angelique Flöter, Estekizadeh, Atosa, Cui, Huanhuan L, Kostopoulou, Ourania N., Davoudi, Belghis, Hirschberg, Angelica Lindén, Carlson, Joseph, Rahbar, Afsar, Söderberg-Naucler, Cecilia
Publikováno v:
In Translational Oncology December 2018 11(6):1292-1300
Autor:
Low, Hann, Mukhamedova, Nigora, Cui, Huanhuan L., McSharry, Brian P., Avdic, Selmir, Hoang, Anh, Ditiatkovski, Michael, Liu, Yingying, Fu, Ying, Meikle, Peter J., Blomberg, Martin, Polyzos, Konstantinos A., Miller, William E., Religa, Piotr, Bukrinsky, Michael, Soderberg-Naucler, Cecilia, Slobedman, Barry, Sviridov, Dmitri
Publikováno v:
In Cell Reports 28 June 2016 16(1):186-200
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.